Johns Hopkins Lung Transplant Program
Evidence level: bibliometric count (PubMed affiliation search); official programme page
Johns Hopkins Lung Transplant Program: selected for this site by publication presence, not an official ranking. PubMed holds 47 lung-transplant CLAD, BOS or chronic rejection records from 2016 to 2026 with an author affiliation naming this institution.
As of . Primary source: Lung Transplant, Johns Hopkins Medicine (official page).
Summary
The official page describes the program as a pioneering leader in lung transplantation for nearly 25 years and states that it offers a limited number of opportunities to take part in national research studies testing ex vivo perfusion. Why it is listed: a PubMed affiliation search run on 2026-10-10 found 47 records for 2016 to 2026 and 39 for 2021 to 2026 that match the CLAD, BOS or chronic rejection lung transplant query and have at least one author affiliation matching "Johns Hopkins". This is a selection by publication presence, not an official ranking, and it does not measure quality, outcomes or superiority. Counts include any record with one author from the institution, not only first or last authors, and affiliation matching is approximate; the exact queries are in docs/CENTRE-SELECTION.md. Papers already in this site whose PubMed record lists an author affiliation naming this institution are linked below; this does not show that the programme itself produced the work.
Details
- city
- Baltimore, Maryland
- country
- United States
- parent
- Johns Hopkins Medicine
- selectionBasis
- Publication presence in PubMed, not an official ranking
- selectionRank
- 8 of 18 by 2016-2026 count (ties in the order shown in docs/CENTRE-SELECTION.md)
- pubmedCount2016to2026
- 47
- pubmedCount2021to2026
- 39
- selectionDate
- 2026-10-10
Sources and links
Related
Links from this record
- author affiliation matches this institution (PubMed): Chronic lung allograft dysfunction is associated with an increased number of non-HLA antibodies
- author affiliation matches this institution (PubMed): Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial
- author affiliation matches this institution (PubMed): Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study
- author affiliation matches this institution (PubMed): Reduced lung fluid club cell secretory protein informs chronic lung allograft dysfunction risk
- author affiliation matches this institution (PubMed): Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation
Known gaps in this record
- funding sources
- founding year and transplant volumes beyond what the official page states (page statements are not verified)
- named CLAD investigators
- a ranking: none exists here, this is a selection by publication presence only
- affiliation counting is approximate (institution names vary, a record counts once if any author matches)
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.